GlobalDeal

Celgene

Biotechnology · Summit, United States

bms.com

About Celgene

Celgene Corporation, now a subsidiary of Bristol-Myers Squibb, is a biopharmaceutical company that discovers, develops, and commercializes innovative therapies for the treatment of cancer and inflammatory disorders. Founded in 1986, Celgene has been at the forefront of developing therapies that target specific pathways in diseases, with a strong emphasis on hematology and oncology. The company is known for its flagship product, Revlimid, which is used in the treatment of multiple myeloma and other blood cancers. Celgene's commitment to research and development has led to a robust pipeline of therapies aimed at improving patient outcomes. The company operates globally, with a focus on delivering high-quality medicines and advancing the science of medicine through collaboration and innovation.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Oncology, Hematology, Immunology, Cell Therapy
Location
Summit, United States
Employees
5K–10K
Founded
1986

Products and services

Open Celgene in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →